Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd
Company Profile
Business description
Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd is a pharmaceutical manufacturing company. The company manufactures and sells traditional Chinese medicine, western medicine, and healthcare products in the People's Republic of China. It operates in two segments namely The Chinese Medicine segment and The Western Medicine segment. The Chinese Medicine segment manufactures Chinese pharmaceutical products under brands owned by the group. The Western Medicine segment manufactures western pharmaceutical products through cooperation with foreign companies. The company earns the majority of its revenue from the sale of Chinese pharmaceutical products.
Contact
No. 17 Baidi Road
Zhong Xin Mansion
Nankai District
Tianjin300193
CHNT: +86 2227020892
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2025
Employees
4,619
Stocks News & Analysis
stocks
Megatrend Investing 2025 and beyond: ASX players to capitalise on the clean energy transition
stocks
DeepSeek revelation hits US chip stocks, ASX data centres and uranium
video
What does a weak Aussie dollar mean for investors?
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,789.70 | 43.80 | 0.50% |
| CAC 40 | 7,941.64 | 69.16 | 0.88% |
| DAX 40 | 21,727.20 | 89.67 | 0.41% |
| Dow JONES (US) | 44,882.13 | 168.61 | 0.38% |
| FTSE 100 | 8,657.49 | 10.61 | 0.12% |
| HKSE | 20,225.11 | 27.34 | 0.14% |
| NASDAQ | 19,681.75 | 49.43 | 0.25% |
| Nikkei 225 | 39,572.49 | 58.52 | 0.15% |
| NZX 50 Index | 12,995.01 | 66.63 | 0.52% |
| S&P 500 | 6,071.17 | 31.86 | 0.53% |
| S&P/ASX 200 | 8,532.30 | 38.60 | 0.45% |
| SSE Composite Index | 3,250.60 | 2.03 | -0.06% |